CYRAMZA (ramucirumab) injection, for intravenous infusion Initial U.S. Approval: 2014 WARNING: HEMORRHAGE See full prescribing information for complete boxed warning. CYRAMZA increased the risk of hemorrhage, including severe and sometimes fatal hemorrhagic events. Permanently discontinue CYRAMZA in patients who experience severe ¿Cuál es la información más importante que debo saber sobre ramucirumab? Ramucirumab puede aumentar su riesgo de un sangrado severo. Deje de usar esta medicina y llame a su médico de inmediato si usted tiene dolor de estómago severo, heces con sangre o alquitranadas, tos con sangre, o cualquier sangrado abundante o inusual. SAFETY DATA SHEET _____ Other Hazards No data available Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the

SAFETY DATA SHEET 1 PRODUCT AND COMPANY IDENTIFICATION ... For waste disposal, see section 13 of the MSDS. Prevent runoff from entering drains, sewers, or streams. 7 ... Material Safety Data Sheet of Exemestane contains identification of substance and details of the supplier of the safety data sheet. SAFETY DATA SHEET 1 PRODUCT AND COMPANY IDENTIFICATION ... For waste disposal, see section 13 of the MSDS. Prevent runoff from entering drains, sewers, or streams. 7 ...